This is a preview of subscription content, log in via an institution to check access.
Literatur
Töteberg-Harms M, Paulsen F, Duncker GI, Sel S (2009) Klinisch-zeitlicher Verlauf eines solitären retinalen Astrozytoms. Ophthalmologe 106:921–923
Mennel S, Eggarter F, Meyer CH, Peter S (2005) Autofluorescence and angiographic findings of retinal astrocytic hamartomas in tuberous sclerosis. Ophthalmologica 219:350–356
Mennel S, Meyer CH, Peter S et al (2007) Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature. Acta Ophthalmol Scand 85:127–132
Mennel S, Hausmann N, Meyer CH, Peter S (2006) Photodynamic therapy for exudative hamartoma in tuberous sclerosis. Arch Ophthalmol 124:597–599
Eskelin S, Tommila P, Palosaari T, Kivelä T (2008) Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomas. Acta Ophthalmol 86:794–799
Shields CL, Materin MA, Marr BP et al (2008) Resolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapy. Arch Ophthalmol 126:273–274
Mennel S, Barbazetto I, Meyer CH et al (2007) Ocular photodynamic therapy–standard applications and new indications (part 1). Review of the literature and personal experience. Ophthalmologica 221:216–226
Cilliers H, Harper CA (2006) Photodynamic therapy with Verteporfin for vascular leakage from a combined hamartoma of the retina and retinal pigment epithelium. Clin Experiment Ophthalmol 34(2):186–188
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Aktuelle Behandlungsindikationen und Behandlungsoptionen bei retinalen astrozytären Hamartomen. Ophthalmologe 107, 377–378 (2010). https://doi.org/10.1007/s00347-010-2156-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-010-2156-1